HW201877
HW201877 is a potent, orally active inhibitor of 15-prostaglandin dehydrogenase (15-PGDH), with an IC50 value of 3.6 nM. It significantly increases PEG2 levels in A549 cells and demonstrates notable efficacy in animal models of tissue injury and fibrosis. HW201877 is utilized in research for inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF), and Crohn's disease (CD) .
Product Specifications
CAS Number
2927452-83-1
Field of Research
Metabolism Research
Smiles
C (=O) (C=1C=C2[C@]3 ([C@] (C3) (CN (C2=NC1) C4=CC=5N (C=C4) C (=O) N (C) N5) [H]) [H]) N6CCC (F) (F) CC6
Molecular Formula
C22H22F2N6O2
Molecular Weight
440.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
397321 100 µg
ABCC1 (Multidrug Resistance-Associated Protein 1, ATP-Binding Cassette Sub-Family C Member 1, Leukotriene C (4) Transporter, LTC4 Transporter, MRP, MRP1)
Sign In for Pricing
View Details 
TBI2898-25MG 25 mg
BMS-345541, IkappaB kinase inhibitor; prevents NFkB activation
Sign In for Pricing
View Details 